Cargando…
Prognostic impact of pretreatment immunoglobulin clonal composition in pediatric B-lymphoblastic leukemia
Autores principales: | Fries, Carol, Lee, Lik Wee, Devidas, Meenakshi, Dai, Yunfeng, Rabin, Karen R., Gupta, Sumit, Loh, Mignon L., Kirsch, Ilan R, Wood, Brent, Rau, Rachel E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973485/ https://www.ncbi.nlm.nih.gov/pubmed/36325891 http://dx.doi.org/10.3324/haematol.2022.281146 |
Ejemplares similares
-
Replacing cyclophosphamide/cytarabine/mercaptopurine with cyclophosphamide/etoposide during consolidation/delayed intensification does not improve outcome for pediatric B-cell acute lymphoblastic leukemia: a report from the COG
por: Burke, Michael J., et al.
Publicado: (2019) -
JAK3 Mutations and Mitochondrial Apoptosis Resistance in T-Cell Acute Lymphoblastic Leukemia
por: Bodaar, Kimberly, et al.
Publicado: (2022) -
SARS‐CoV‐2 infections in patients enrolled on the Children's Oncology Group standard‐risk B‐cell acute lymphoblastic leukemia trial, AALL1731
por: Elgarten, Caitlin W., et al.
Publicado: (2023) -
Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemia
por: Burns, Melissa A., et al.
Publicado: (2018) -
PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia
por: Ariës, Ingrid M., et al.
Publicado: (2018)